NCT03812159 is a NA clinical trial of iCSPlan in Craniosynostoses, sponsored by Gary F. Rogers, MD.

Who is sponsoring NCT03812159?

NCT03812159 is sponsored by Gary F. Rogers, MD.

What drugs are being tested in NCT03812159?

Interventions in NCT03812159: iCSPlan.

What condition does NCT03812159 study?

NCT03812159 studies Craniosynostoses.

Is NCT03812159 still recruiting?

NCT03812159 is currently withdrawn. Last updated 8 February 2024.

Last reviewed 2024-02-08 · How we verify

NCT03812159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Feasibility Study of Preoperative Surgical Planning

Withdrawn NA Last updated 8 February 2024

What this trial tests

NA trial testing iCSPlan in Craniosynostoses. Withdrawn.

Timeline

1 January 2020

Primary endpoint
20 March 2024

20 April 2024

Quick facts

Lead sponsor	Gary F. Rogers, MD
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Start date	1 January 2020
Primary completion	20 March 2024
Estimated completion	20 April 2024
Sites	1 location across United States

Drugs / interventions tested

iCSPlan

Conditions studied

Craniosynostoses — all drugs for Craniosynostoses →

Sponsor

Gary F. Rogers, MD

Who can join

Under 18, any sex, with Craniosynostoses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most children diagnosed with craniosynostosis undergo a relatively extensive cranial vault remodeling procedure. The decision of performing surgical cranial shape correction for patients with craniosynostosis typically rests on a subjective visual assessment of the severity of the cranial malformation and the main goal of this procedure is to reduce the risk of elevated intracranial pressure and to provide a more normal cranial shape and volume. Personalized surgical planning systems to optimize intervention and leverage surgical expertise in the reconstruction of the cranial vault do not exist. Thus, the expertise of the surgeon is paramount for the success of the surgical correction of craniosynostosis. The goal of our project is to evaluate the feasibility and utility of a surgical plan derived from software developed at Children's National, iCSPlan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Craniosynostoses

Currently open trials in the same condition.

NCT06533150 — Functionalized Bioink Delivering Biomolecules for the Treatment of Craniofacial Diseases · active not recruiting
NCT04159675 — Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03812159 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gary F. Rogers, MD
Last refreshed: 8 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03812159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing